Featured Research

from universities, journals, and other organizations

Psoriasis increases risk of diabetes, study shows

Date:
June 18, 2012
Source:
University of Pennsylvania School of Medicine
Summary:
Psoriasis is an independent risk for Type 2 Diabetes, according to a new study, with the greatest risk seen in patients with severe psoriasis. Researchers estimate that an additional 115,500 people will develop diabetes each year due to the risk posed by psoriasis above and beyond conventional risk factors.

Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis. Researchers estimate that an additional 115,500 people will develop diabetes each year due to the risk posed by psoriasis above and beyond conventional risk factors.

The research is published in the latest issue of the Archives of Dermatology, a JAMA Network publication.

"These data suggest that patients with psoriasis are at increased risk for developing diabetes even if they don't have common risk factors such as obesity," said senior author Joel M. Gelfand, MD, MSCE, associate professor of Dermatology in the Perelman School of Medicine. "Patients with psoriasis should eat a healthy diet, get regular exercise, and see their physician for routine preventative health screenings such as checks of blood pressure, cholesterol, and blood sugar."

Psoriasis is a common inflammatory skin disease affecting over 7.5 million Americans and causes thick, inflamed, scaly patches of skin. The disease has previously been associated with increased risk of myocardial infarction, stroke, metabolic syndrome and cardiovascular mortality.

This research builds on previous work demonstrating a diverse set of increased health risks for people with psoriasis," said lead author Rahat S. Azfar, MD, MSCE, adjunct assistant professor of Dermatology in the Perelman School of Medicine. "In addition to having an increased risk of diabetes, people with psoriasis are more likely to have metabolic syndrome, high triglycerides, and raised glucose levels, even if they are not overweight or have other common risk factors for these conditions. Both patients with psoriasis, especially those with severe psoriasis, and their treating physicians should be aware of the potential for systemic metabolic complications associated with this skin disease.

Both psoriasis and diabetes are diseases caused by chronic inflammation. A shared pathway -- TH-1 cytokines -- can promote insulin resistance and metabolic syndrome, and promote inflammatory cytokines known to drive psoriasis.

The study compared 108,132 people with psoriasis to 430,716 matched patients without psoriasis, and determined patients with mild psoriasis had an 11% increased risk of diabetes and patients with severe psoriasis had a 46% higher risk compared to patients without psoriasis. The study also looked at treatments used by those diagnosed with diabetes, and found that the patients with both psoriasis and diabetes were more likely to require pharmacological treatment of diabetes, compared to diabetics without psoriasis.

Researchers noted that future studies should look into the extent to which psoriasis and its treatment play a role in the development of Type 2 Diabetes and its complications.

The research team includes Daniel B. Shin, BA, Andrea B. Troxel, ScD, David J. Margolis, MD, PhD, from Penn's Dermatology and Biostatistics and Epidemiology departments and the Center for Clinical Epidemiology and Biostatistics. The work was done in collaboration with co-lead author Nicole M. Seminara, MD, from the Department of Internal Medicine at the New York University Langone Medical Center.

The research was funded by grants from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (F32-AR056799), the National Heart, Lung, and Blood Institute (3R01HL089744-01A2S1, R01HL089744-03)and a T32 University of Pennsylvania dermatology departmental training grant.

Dr. Gelfand has received grants from Amgen, Pfizer, Novartis, and Abbott, and is a consultant for Amgen, Abbott, Pfizer, Novartis, Celgene, and Centocor. Dr. Margolis is on the data safety monitoring boards for Abbott, Astellas, and Centocor.


Story Source:

The above story is based on materials provided by University of Pennsylvania School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nicole M. Seminara. Increased Risk of Diabetes Mellitus and Likelihood of Receiving Diabetes Mellitus Treatment in Patients With PsoriasisDiabetes Mellitus and Psoriasis. Archives of Dermatology, 2012; 1 DOI: 10.1001/archdermatol.2012.1401

Cite This Page:

University of Pennsylvania School of Medicine. "Psoriasis increases risk of diabetes, study shows." ScienceDaily. ScienceDaily, 18 June 2012. <www.sciencedaily.com/releases/2012/06/120618161820.htm>.
University of Pennsylvania School of Medicine. (2012, June 18). Psoriasis increases risk of diabetes, study shows. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2012/06/120618161820.htm
University of Pennsylvania School of Medicine. "Psoriasis increases risk of diabetes, study shows." ScienceDaily. www.sciencedaily.com/releases/2012/06/120618161820.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins